SlideShare a Scribd company logo
MENOPAUSE
UPDATE
Staying cool while keeping hot
How to diagnose Menopause?
In a woman > 45 years of age, diagnose
• Perimenopause
• If she is having vasomotor symptoms and irregular periods
• Menopause (with uterus)
• If her last menstrual period was >12 months ago and she is not
using hormonal contraception
• Menopause (without uterus)
• If she has climacteric symptoms
NICE guideline : Menopause: diagnosis and management, 2015
FSH measurement
Consider using FSH to diagnose menopause only in:
• Women aged 40-45 years with menopausal symptoms +
change in menstrual cycle
• Women aged <40 years in whom menopause is suspected
• FSH > 35miu/ml in 2 separate occasions 6 weeks apart
NICE guideline : Menopause: diagnosis and management, 2015
Average age of Menopause
• Mean age of menopause in Malaysia = 50.7 years
• Average life expectancy of Malaysian women = 74 years
First Consensus Meeting on Menopause in the East Asian Region – Menopause
and HRT in Malaysia
Physiology of Menopause
• Menopause occurs when the ovary runs out of eggs
• This results in reduced estradiol (E2) and increased FSH
• Therefore, symptoms of menopause relate to estrogen
deficiency
During perimenopause,
• There can be wide variation in hormone levels
• Women can present with a mixture of both estrogen excess
and estrogen deficiency symptoms
• Symptoms of estrogen excess include breast tenderness,
menorrhagia, migraine, nausea, shorter cycle length, shorter
follicular phase
Climacteric Symptoms
MUM’S Vagina
• Musculoskeletal symptoms
• Joint and muscle pain
• Urogenital symptoms
• Vaginal dryness / itching, dyspareunia, urinary frequency/urgency
• Mood changes
• Irritability, depressive sx, sleep disturbance, reduced
concentration
• Sexual difficulties
• Loss of libido
• Vasomotor symptoms
• Hot flushes, night sweats
Symptom Prevalence
In the US
• African-American > Caucasian > Chinese > Japanese
In the UK
• 1 in 4 experience severe VMS
• 1 in 3 experience severe psychological symptoms (anxiety,
depression)
• 1 in 2 experience moderate to severe symptoms of sleep
disturbance, joint pain or headache
• 1 in 4 have sexual problems
F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the
Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
Symptom Prevalence
In Malaysia
• 52% felt that symptoms affected their quality of life
• Only 2.7% reported severe symptoms
Bahiyah Abdullah et al, Prevalence of menopausal symptoms, its effect to quality of life
among Malaysian women and their treatment seeking behaviour, Med J Malaysia Vol 72
Symptom Prevalence
Joint pains / Muscular discomfort 24%
Fatigue / Irritabiliry 60%
VSM symptoms 55%
Depression / Anxiety 45%
Vaginal dryness 41%
Sexual problems 35%
Symptom Duration
• There is no age limit at which menopausal symptoms cease
• 10% of women have VMS 10 years after menopause
• 16% of 85 year olds continue to experience VMS
F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the
Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
Other Health Consequences of
Menopause
Metabolic
• Central abdominal fat deposition
• Insulin resistance / T2DM
Cardiovascular
• Impaired endothelial function
• Increased cholesterol
Skeletal
• Accelerated bone loss
• Increased fracture risk
Neurological
• ? Cognitive performance decline
Urogenital
• Atrophic vaginitis
• Urinary tract – frequency, cystitis, urge incontinence, dysuria
Cancer
• Breast / cervical / colon
Other Health Consequences of
Menopause
Indications for starting HRT
• Management of menopausal symptoms
• VSM symptoms
• Mood disorders
• Altered sexual function
• Urogenital atrophy
• Prevention of Osteoporosis
Indications for Treatment
Complaint 1st line treatment 2nd line treatment
Vasomotor symptoms HRT SSRI, SNRI, Clonidine
Black cohosh
Low mood HRT CBT
SNRI/SSRI only for
diagnosed depression
Reduced libido HRT / Tibolone Add on Testosterone
Urogenital atrophy Vaginal estrogen Add on moisturisers,
lubricants
High risk of osteoporosis HRT ( <60 yo) Bisphosphonates,
Denosumab, SERM
NICE guideline : Menopause: diagnosis and management, 2015
Treatment options
HRT
• Estrogen only – ERT (Only to be used in women w/out uterus)
• Oral / Patch / Vaginal
• Estrogen + Progestogen – E+P
• Oral / Patch
• Continuous HRT or Sequential HRT
Other options
• Tibolone
• TSEC (Tissue-selective estrogen complex therapy)
• Estrogen + SERM
• SSRI / SNRI
Contraindication for HRT
• History of breast cancer
• History of VTE / stroke
• Undiagnosed uterine bleeding
• Significant cardiovascular disease
• Hypersensitivity to estrogen
• Active liver disease
• Fibroids / endometriosis (Relative contraindications)
Timing of Initiation
• Best to start within 10 years of menopause
• Should NOT start HRT above 60 yo without STRONG indication
• In premature menopause, HRT is recommended until at least
age of ‘natural’ menopause ie 50yo
Dosages
Use the LOWEST EFFECTIVE dose
of estrogen consistent with
TREATMENT GOALS
• All women with an intact uterus will require progestogen.
• Younger women generally require higher doses than older
women
Dosages
Estrogen Standard dose Low dose
Conjugated equine estrogen (CEE) 0.625mg 0.3mg
17ẞ estradiol valerate 2.0mg 0.5 – 1.0mg
Micronised estradiol 1.0 – 2.0mg 0.25 – 0.5mg
Transdermal estradiol 50-100mcg 25mcg
Progestogen Standard dose Low dose
Medroxyprogesterone acetate 2.5 – 5.0mg 1.5mg
Norethisterone acetate (NETA) 1.0 – 2.0mg 0.1 – 0.5mg
Drosperinone 2.0mg 0.5mg
Micronised progesterone 100mc 50mg
Tibolone Dose
Tibolone 2.5mg daily
Which is better?
• CEE and Micronised Estradiol found to have lowest risk of
increase in VTE
• Micronised progesterone and Dydrogesterone found to have
lower risk of breast cancer
Pre-treatment evaluation
General examination
• Medical history
• Family history
• Weight/Height/BMI
• Blood pressure
• Breast examination
• Bimanual
examination
• Papsmear
Optional Investigations
• Lipid profile
• FBS
• FBC
• Buse/Cr
• LFT
• TFT
• BMD
• Mammogram
Mammography screening should be done 2 yearly from 50-74 yo – US
Preventive Task Force (USPTF) 2009
Duration of use
• NO MANDATORY duration
• HRT can be given for AS LONG AS THE WOMAN WANTS IT
• Ensure adequate supervision – annual risk-benefit assessment
• Ensure woman aware of risks and benefits
Clinical Side Effects of HRT
Estrogen excess
• Nausea, headache, breast tenderness
• May be reduced by transdermal estrogen
• Try changing to a different preparation
E+P HT
• Heavy bleeding, low mood
• Micronised progesterone may have less mood side effects
Long Term Effects of HRT
• VTE
• Stroke
• Cardiovascular disease
• Breast cancer
• Type 2 diabetes
• Osteoporosis
NICE guideline : Menopause: diagnosis and management, 2015
VTE and HRT
• Micronised progesterone has lower risk of CTE compared to
other types of progesterone
• Estradiol may have lower risk of VTE compared to other types
of estrogen
• E only – 4 additional cases per 10 000 woman years
• E+P – 6 additional cases per 10 000 woman years
• Transdermal estrogen patch is NOT SHOWN to increase VTE
• Patch should be used in women with increased risk of VTE
R. J. Baber, N. Panay & A. Fenton the IMS Writing Group (2016) 2016 IMS Recommendations on women’s
midlife health and menopause hormone therapy, Climacteris, 19:2, 109-150, DOI: 10.3109-
13697137.2015.1129166
Stroke and HRT
• HRT in women <60 years of age and <10 years since
menopause is not shown to increase risk in stroke
• WHI study
• Small increased risk of stroke in women taking oral estrogen
>60 yo (but not transdermal estrogen!)
Cardiovascular disease & HRT
• HRT does NOT increase cardiovascular disease risk when
started in women <60 yo
• Risk of cardiovascular disease depends largely on other factors
• HRT with estrogen alone is associated with no, or REDUCED
risk of coronary heart disease
• HRT with E+P is associated with little or no increase in the risk
of coronary heart disease (up to 5 more women per 1000
women)
• DOPs study – reduction in risk of CVD present up to 16 years
later
NICE guideline : Menopause: diagnosis and management, 2015
Breast cancer & HRT
• Estrogen ALONE is associated with little or NO CHANGE in the
risk of breast cancer
• E+P is associated with a small increase in risk of breast cancer
• Up to 5 more cases per 1000 women
• Any increase in risk will reduce after stopping HRT
• Micronised progesterone may have lower risk
NICE guideline : Menopause: diagnosis and management, 2015
Type 2 diabetes & HRT
• No contraindication for HRT
• Not shown to have any impact on DM
Osteoporosis and HRT
• T-score
• Osteopenia -1 to -2.4
• Osteoporosis -2.5 or lower
• Osteoporosis depends on multiple factors including genetics
and lifestyle
• HRT significantly reduces the risk of fragility fracture but the
benefits decrease once treatment is stopped
• 23 fewer fractures per 1000 women
NICE guideline : Menopause: diagnosis and management, 2015
Summary of Long Term Effects
of HRT
E only E+P
VTE
Baseline risk 1:1000
+4 per 10 000 women
No increase in transdermal
+6 per 10 000 women
Stroke
Baseline risk 11:1000
No increase in transdermal +6 per 1000 women
CHD
Baseline risk 26:1000
-6 per 1000 women +5 per 1000 women
Breast cancer
Baseline risk 22:1000
-4 per 1000 women +5 per 1000 women
Osteoporosis
Baseline : variable
-23 per 1000 women -23 per 1000 women
NICE guideline : Menopause: diagnosis and management, 2015
Summary of Long Term Effects
of HRT
E only E+P
VTE
Baseline risk 1:1000
+ / = +
Stroke
Baseline risk 11:1000
+ / = +
CHD
Baseline risk 26:1000
 +
Breast cancer
Baseline risk 22:1000
 +
Osteoporosis
Baseline : variable
 
Perimenopausal Women
GOALS – Cycle control, Contraception, Symptom control
• OCP
• Rule out CI eg smoking, hypertension, dyslipidaemia, migraine,
thrombosis risk, CVS risk
• Consider switching to estradiol containing OCP rather than EE
• Progestogen only contraception
• Oral progestogens may be helpful in cycle control but not
symptoms
• LNG-IUS can be combined with oral estrogen for symptom control
• Cyclical MHT
• MHT does not suppress ovulation hence there may be symptoms
of estrogen excess eg mastalgia, erratic bleeding
Perimenopausal Women
HRT is NOT EFFECTIVE CONTRACEPTION!
Tibolone
• Estrogenic, progestogenic and androgenic action
• Contraindicated for breast cancer patients
Improvement Increased Risk
Libido /
Osteoporosis /
Stroke >60yo – 2x risk
Breast cancer Reduced risk
Colon cancer Reduced risk
Endometrial
hyperplasia
No impact
F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the
Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
TSEC – Tissue-selectiveestrogencomplextherapy
• SERM + Estrogen
• CEE 0.45mg/day + Bazedoxifene 20mg /day
• Reduces VMS
• Improves urogenital atrophy
• Preserves bone mass
• Does not stimulate the endometrium
• No evidence to increase VTE
• No increase in breast cancer
F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the
Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
SSRI / SNRI
• Second line treatment for VMS
• May also improve mood and well-being
• Not indicated for low mood without clinical depression
HRT available in Malaysia
Brand name Hormonal content Dosage
Angeliq Estradiol hemihydrate
+ Drosperinone
1.0mg
2.0mg
Climen - 16 pills
- 12 pills
Estradiol valerate
Estradiol valerate
+ cyproterone acetate
2.0mg
2.0mg
1.0mg
Divigel gel
(28 sachets)
Estradiol 1mg/g
HRT available in Malaysia
Brand name Hormonal content Dosage
Femoston
2/10 14 pills
14 pills
Estradiol
Estradiol
+ dydrogesterone
2.0mg
2.0mg
10.0mg
Femoston
1/10 14 pills
14 pills
Estradiol
Estradiol
+ dydrogesterone
1.0mg
1.0mg
10.0mg
Femoston contii Estradiol
+ dydrogesterone
1.0mg
5.0mg
HRT available in Malaysia
Brand name Hormonal content Dosage
Oestrogel gel 17ẞ estradiol 1.5mg/2.5g gel
Permarin Conjugated equine
estrogen
0.3mg, 0.625mg
Premarin vaginal cream Conjugated equine
estrogen
0.3mg/0.625mg/42.5g
Premelle 2.5 CEE
+ MPA
0.625mg
2.5mg
Premelle 5.0 CEE
+ MPA
0.625mg
5mg
HRT available in Malaysia
Brand Name Hormonal content Dosage
Progynova Estradiol valerate 1.0mg or 2.0mg
Progyluton - 11 pills
- 10 pills
Estradiol valerate
Estradiol valerate
+ norgestrel
2.0mg
2.0mg
500mcg
Summary
• Current evidence indicates that HRT BENEFITS OUTWEIGHS
HARM
• HRT should be given to symptomatic women / women at high
risk of osteoporotic fractures
• Clinicians have an important role to offer HRT after
appropriate counselling and ruling out any contraindications
• The lowest dose of estrogen consistent with treatment goals
should be used
• HRT can be given for as long as the woman wants
• Review women on HRT 6-12 monthly TRO any new
contraindications
• All menopausal women should be given advice on healthy
lifestyle and ideal weight.
THANK YOU!

More Related Content

What's hot

Post menopausal bleeding
Post menopausal bleedingPost menopausal bleeding
Post menopausal bleeding
dr.hafsa asim
 
How to approch a case of amenorrhea
How to approch a case of amenorrheaHow to approch a case of amenorrhea
How to approch a case of amenorrhea
Faculty of Medicine,Zagazig University,EGYPT
 
Endometriosis: ESHRE2014& NICE2017 Guidelines
Endometriosis: ESHRE2014& NICE2017 GuidelinesEndometriosis: ESHRE2014& NICE2017 Guidelines
Endometriosis: ESHRE2014& NICE2017 Guidelines
Aboubakr Elnashar
 
Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)
Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)
Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)
Dr.Laxmi Agrawal Shrikhande
 
ADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSISADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSIS
Aboubakr Elnashar
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
Aboubakr Elnashar
 
Post Menopausal Bleeding
Post Menopausal BleedingPost Menopausal Bleeding
Post Menopausal Bleeding
AthulaKaluarachchi1
 
Menopause
MenopauseMenopause
Menopause
Priti Bhatt
 
Menopause
Menopause Menopause
ENDOMETRIOSIS
ENDOMETRIOSISENDOMETRIOSIS
ENDOMETRIOSIS
NARENDRA MALHOTRA
 
Menopause ppt
Menopause pptMenopause ppt
Menopause ppt
Diana Lou
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
Marwan Alhalabi
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
Sujoy Dasgupta
 
Dysmenorrhoea and premenstrual syndrome
Dysmenorrhoea and premenstrual syndromeDysmenorrhoea and premenstrual syndrome
Dysmenorrhoea and premenstrual syndrome
Dr Kishwar Naheed
 
Puberty menorrhagia Dr Sharda Jain , Dr Jyoti Agarwal
Puberty menorrhagia  Dr Sharda Jain , Dr Jyoti Agarwal Puberty menorrhagia  Dr Sharda Jain , Dr Jyoti Agarwal
Puberty menorrhagia Dr Sharda Jain , Dr Jyoti Agarwal
Lifecare Centre
 
Menopause
MenopauseMenopause
Menopause
Abie Dabs
 
Menopauseppt 130119091724-phpapp02
Menopauseppt 130119091724-phpapp02Menopauseppt 130119091724-phpapp02
Menopauseppt 130119091724-phpapp02
gayathri g krishnan
 
Treatment of hot flashes
Treatment of hot flashesTreatment of hot flashes
Treatment of hot flashes
Aboubakr Elnashar
 
gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)student
 
Management of hyperemesis gravidarum rcog 2016
Management of hyperemesis gravidarum  rcog 2016Management of hyperemesis gravidarum  rcog 2016
Management of hyperemesis gravidarum rcog 2016
Dr Meenakshi Sharma
 

What's hot (20)

Post menopausal bleeding
Post menopausal bleedingPost menopausal bleeding
Post menopausal bleeding
 
How to approch a case of amenorrhea
How to approch a case of amenorrheaHow to approch a case of amenorrhea
How to approch a case of amenorrhea
 
Endometriosis: ESHRE2014& NICE2017 Guidelines
Endometriosis: ESHRE2014& NICE2017 GuidelinesEndometriosis: ESHRE2014& NICE2017 Guidelines
Endometriosis: ESHRE2014& NICE2017 Guidelines
 
Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)
Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)
Presentation on The Diagnosis of Polycystic Ovary Syndrome (PCOS)
 
ADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSISADOLESCENT ENDOMETRIOSIS
ADOLESCENT ENDOMETRIOSIS
 
Endometriosis
EndometriosisEndometriosis
Endometriosis
 
Post Menopausal Bleeding
Post Menopausal BleedingPost Menopausal Bleeding
Post Menopausal Bleeding
 
Menopause
MenopauseMenopause
Menopause
 
Menopause
Menopause Menopause
Menopause
 
ENDOMETRIOSIS
ENDOMETRIOSISENDOMETRIOSIS
ENDOMETRIOSIS
 
Menopause ppt
Menopause pptMenopause ppt
Menopause ppt
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
 
Endometriosis and Infertility
Endometriosis and InfertilityEndometriosis and Infertility
Endometriosis and Infertility
 
Dysmenorrhoea and premenstrual syndrome
Dysmenorrhoea and premenstrual syndromeDysmenorrhoea and premenstrual syndrome
Dysmenorrhoea and premenstrual syndrome
 
Puberty menorrhagia Dr Sharda Jain , Dr Jyoti Agarwal
Puberty menorrhagia  Dr Sharda Jain , Dr Jyoti Agarwal Puberty menorrhagia  Dr Sharda Jain , Dr Jyoti Agarwal
Puberty menorrhagia Dr Sharda Jain , Dr Jyoti Agarwal
 
Menopause
MenopauseMenopause
Menopause
 
Menopauseppt 130119091724-phpapp02
Menopauseppt 130119091724-phpapp02Menopauseppt 130119091724-phpapp02
Menopauseppt 130119091724-phpapp02
 
Treatment of hot flashes
Treatment of hot flashesTreatment of hot flashes
Treatment of hot flashes
 
gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)gynaecology.Sec amenorrhea.(dr.hana)
gynaecology.Sec amenorrhea.(dr.hana)
 
Management of hyperemesis gravidarum rcog 2016
Management of hyperemesis gravidarum  rcog 2016Management of hyperemesis gravidarum  rcog 2016
Management of hyperemesis gravidarum rcog 2016
 

Similar to Menopause

Hormone Replacement Therapy and Breast Cancer
Hormone Replacement Therapy and Breast CancerHormone Replacement Therapy and Breast Cancer
Hormone Replacement Therapy and Breast Cancer
Kervindran Mohanasundaram
 
Case Based Panel Discussion on Menopausal health
Case Based Panel Discussion on Menopausal healthCase Based Panel Discussion on Menopausal health
Case Based Panel Discussion on Menopausal health
Sujoy Dasgupta
 
Polycyctic ovarian disease
Polycyctic ovarian diseasePolycyctic ovarian disease
Polycyctic ovarian disease
Dr Nupur Gupta High Risk Obstetrician
 
What every doctor should know about pcos
What every doctor should know about pcosWhat every doctor should know about pcos
What every doctor should know about pcos
Dr.Laxmi Agrawal Shrikhande
 
Pcos
PcosPcos
Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...
Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...
Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...
Cleveland HeartLab, Inc.
 
menopause_and_hrt-28_mar_18_0.ppt
menopause_and_hrt-28_mar_18_0.pptmenopause_and_hrt-28_mar_18_0.ppt
menopause_and_hrt-28_mar_18_0.ppt
Drricha Agarwalmodi
 
Richard-Davis Menopause Tex Tech 2016 final_2.pptx
Richard-Davis Menopause Tex Tech 2016 final_2.pptxRichard-Davis Menopause Tex Tech 2016 final_2.pptx
Richard-Davis Menopause Tex Tech 2016 final_2.pptx
estelaabera
 
Precious Puberty
Precious PubertyPrecious Puberty
Management of menopause
Management of menopauseManagement of menopause
Management of menopause
Amir Mahmoud
 
Menopause womens health
Menopause womens health Menopause womens health
Menopause womens health
Physioaadhar Physiotherapy Services
 
Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)
Wael Mohamed
 
PREMATURE OVARIAN INSUFFICIENCY (POI)
PREMATURE OVARIAN INSUFFICIENCY(POI)PREMATURE OVARIAN INSUFFICIENCY(POI)
PREMATURE OVARIAN INSUFFICIENCY (POI)
Dr. Sunita Chandra
 
Menopause
MenopauseMenopause
B agusala womens health final
B agusala womens health finalB agusala womens health final
B agusala womens health final
katejohnpunag
 
Polycystic Ovarian Disease
Polycystic Ovarian Disease Polycystic Ovarian Disease
Polycystic Ovarian Disease
Dr Nupur Gupta High Risk Obstetrician
 
Menopause & HRT
Menopause & HRTMenopause & HRT
Menopause & HRT
priyadharshini manickam
 
Premenstrual tension syndrome hennawy
Premenstrual  tension syndrome  hennawyPremenstrual  tension syndrome  hennawy
Premenstrual tension syndrome hennawy
muhammad al hennawy
 
01.Menopause.pptx
01.Menopause.pptx01.Menopause.pptx
01.Menopause.pptx
LIVINGALONE1
 

Similar to Menopause (20)

Hormone Replacement Therapy and Breast Cancer
Hormone Replacement Therapy and Breast CancerHormone Replacement Therapy and Breast Cancer
Hormone Replacement Therapy and Breast Cancer
 
Case Based Panel Discussion on Menopausal health
Case Based Panel Discussion on Menopausal healthCase Based Panel Discussion on Menopausal health
Case Based Panel Discussion on Menopausal health
 
Polycyctic ovarian disease
Polycyctic ovarian diseasePolycyctic ovarian disease
Polycyctic ovarian disease
 
What every doctor should know about pcos
What every doctor should know about pcosWhat every doctor should know about pcos
What every doctor should know about pcos
 
Pcos
PcosPcos
Pcos
 
Menopause
MenopauseMenopause
Menopause
 
Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...
Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...
Holly Thacker, Update on: Menopause, Hormone Therapy, Sex, Politics, and the ...
 
menopause_and_hrt-28_mar_18_0.ppt
menopause_and_hrt-28_mar_18_0.pptmenopause_and_hrt-28_mar_18_0.ppt
menopause_and_hrt-28_mar_18_0.ppt
 
Richard-Davis Menopause Tex Tech 2016 final_2.pptx
Richard-Davis Menopause Tex Tech 2016 final_2.pptxRichard-Davis Menopause Tex Tech 2016 final_2.pptx
Richard-Davis Menopause Tex Tech 2016 final_2.pptx
 
Precious Puberty
Precious PubertyPrecious Puberty
Precious Puberty
 
Management of menopause
Management of menopauseManagement of menopause
Management of menopause
 
Menopause womens health
Menopause womens health Menopause womens health
Menopause womens health
 
Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)Adolescent poly cystic ovary (PCO)
Adolescent poly cystic ovary (PCO)
 
PREMATURE OVARIAN INSUFFICIENCY (POI)
PREMATURE OVARIAN INSUFFICIENCY(POI)PREMATURE OVARIAN INSUFFICIENCY(POI)
PREMATURE OVARIAN INSUFFICIENCY (POI)
 
Menopause
MenopauseMenopause
Menopause
 
B agusala womens health final
B agusala womens health finalB agusala womens health final
B agusala womens health final
 
Polycystic Ovarian Disease
Polycystic Ovarian Disease Polycystic Ovarian Disease
Polycystic Ovarian Disease
 
Menopause & HRT
Menopause & HRTMenopause & HRT
Menopause & HRT
 
Premenstrual tension syndrome hennawy
Premenstrual  tension syndrome  hennawyPremenstrual  tension syndrome  hennawy
Premenstrual tension syndrome hennawy
 
01.Menopause.pptx
01.Menopause.pptx01.Menopause.pptx
01.Menopause.pptx
 

More from Kervindran Mohanasundaram

Surgical Site Infection (Obstetrics and Gynaecology)
Surgical Site Infection (Obstetrics and Gynaecology)Surgical Site Infection (Obstetrics and Gynaecology)
Surgical Site Infection (Obstetrics and Gynaecology)
Kervindran Mohanasundaram
 
Care in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal DeathCare in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal Death
Kervindran Mohanasundaram
 
Ocular Manifestations in Pregnancy and Labour
Ocular Manifestations in Pregnancy and LabourOcular Manifestations in Pregnancy and Labour
Ocular Manifestations in Pregnancy and Labour
Kervindran Mohanasundaram
 
Solid Organ Transplantation in Pregnancy (Kidney and Liver)
Solid Organ Transplantation in Pregnancy (Kidney and Liver)Solid Organ Transplantation in Pregnancy (Kidney and Liver)
Solid Organ Transplantation in Pregnancy (Kidney and Liver)
Kervindran Mohanasundaram
 
Preterm breech, vaginal delivery or caesarean section?
Preterm breech, vaginal delivery or caesarean section?Preterm breech, vaginal delivery or caesarean section?
Preterm breech, vaginal delivery or caesarean section?
Kervindran Mohanasundaram
 
Latest Figo Classification for Cervical Cancer
Latest Figo Classification for Cervical Cancer Latest Figo Classification for Cervical Cancer
Latest Figo Classification for Cervical Cancer
Kervindran Mohanasundaram
 
Bleeding in Early Pregnancy Update April 2019
Bleeding in Early Pregnancy Update April 2019Bleeding in Early Pregnancy Update April 2019
Bleeding in Early Pregnancy Update April 2019
Kervindran Mohanasundaram
 
Contraception Update April 2019
Contraception Update April 2019Contraception Update April 2019
Contraception Update April 2019
Kervindran Mohanasundaram
 
Cervical Screening and Colposcopy Update April 2019
Cervical Screening and Colposcopy Update April 2019Cervical Screening and Colposcopy Update April 2019
Cervical Screening and Colposcopy Update April 2019
Kervindran Mohanasundaram
 
Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019
Kervindran Mohanasundaram
 
Anaemia in Pregnancy Update April 2019
Anaemia in Pregnancy Update April 2019Anaemia in Pregnancy Update April 2019
Anaemia in Pregnancy Update April 2019
Kervindran Mohanasundaram
 
Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019
Kervindran Mohanasundaram
 
PAPseek - Screening for endometrial and ovarian cancers
PAPseek - Screening for endometrial and ovarian cancersPAPseek - Screening for endometrial and ovarian cancers
PAPseek - Screening for endometrial and ovarian cancers
Kervindran Mohanasundaram
 
Nausicaa Compression Suture
Nausicaa Compression SutureNausicaa Compression Suture
Nausicaa Compression Suture
Kervindran Mohanasundaram
 
Pre-eclampsia
Pre-eclampsiaPre-eclampsia
Genital Skin Lesions
Genital Skin LesionsGenital Skin Lesions
Genital Skin Lesions
Kervindran Mohanasundaram
 
Progestin-based Contraception
Progestin-based ContraceptionProgestin-based Contraception
Progestin-based Contraception
Kervindran Mohanasundaram
 
Postmenopausal Osteoporosis
Postmenopausal OsteoporosisPostmenopausal Osteoporosis
Postmenopausal Osteoporosis
Kervindran Mohanasundaram
 
Non-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCPNon-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCP
Kervindran Mohanasundaram
 
Managing Endometriosis
Managing EndometriosisManaging Endometriosis
Managing Endometriosis
Kervindran Mohanasundaram
 

More from Kervindran Mohanasundaram (20)

Surgical Site Infection (Obstetrics and Gynaecology)
Surgical Site Infection (Obstetrics and Gynaecology)Surgical Site Infection (Obstetrics and Gynaecology)
Surgical Site Infection (Obstetrics and Gynaecology)
 
Care in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal DeathCare in Pregnancies Subsequent to Stillbirth or Perinatal Death
Care in Pregnancies Subsequent to Stillbirth or Perinatal Death
 
Ocular Manifestations in Pregnancy and Labour
Ocular Manifestations in Pregnancy and LabourOcular Manifestations in Pregnancy and Labour
Ocular Manifestations in Pregnancy and Labour
 
Solid Organ Transplantation in Pregnancy (Kidney and Liver)
Solid Organ Transplantation in Pregnancy (Kidney and Liver)Solid Organ Transplantation in Pregnancy (Kidney and Liver)
Solid Organ Transplantation in Pregnancy (Kidney and Liver)
 
Preterm breech, vaginal delivery or caesarean section?
Preterm breech, vaginal delivery or caesarean section?Preterm breech, vaginal delivery or caesarean section?
Preterm breech, vaginal delivery or caesarean section?
 
Latest Figo Classification for Cervical Cancer
Latest Figo Classification for Cervical Cancer Latest Figo Classification for Cervical Cancer
Latest Figo Classification for Cervical Cancer
 
Bleeding in Early Pregnancy Update April 2019
Bleeding in Early Pregnancy Update April 2019Bleeding in Early Pregnancy Update April 2019
Bleeding in Early Pregnancy Update April 2019
 
Contraception Update April 2019
Contraception Update April 2019Contraception Update April 2019
Contraception Update April 2019
 
Cervical Screening and Colposcopy Update April 2019
Cervical Screening and Colposcopy Update April 2019Cervical Screening and Colposcopy Update April 2019
Cervical Screening and Colposcopy Update April 2019
 
Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019Prepregnancy Care Update April 2019
Prepregnancy Care Update April 2019
 
Anaemia in Pregnancy Update April 2019
Anaemia in Pregnancy Update April 2019Anaemia in Pregnancy Update April 2019
Anaemia in Pregnancy Update April 2019
 
Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019Hypertensive Disorders in Pregnancy Update April 2019
Hypertensive Disorders in Pregnancy Update April 2019
 
PAPseek - Screening for endometrial and ovarian cancers
PAPseek - Screening for endometrial and ovarian cancersPAPseek - Screening for endometrial and ovarian cancers
PAPseek - Screening for endometrial and ovarian cancers
 
Nausicaa Compression Suture
Nausicaa Compression SutureNausicaa Compression Suture
Nausicaa Compression Suture
 
Pre-eclampsia
Pre-eclampsiaPre-eclampsia
Pre-eclampsia
 
Genital Skin Lesions
Genital Skin LesionsGenital Skin Lesions
Genital Skin Lesions
 
Progestin-based Contraception
Progestin-based ContraceptionProgestin-based Contraception
Progestin-based Contraception
 
Postmenopausal Osteoporosis
Postmenopausal OsteoporosisPostmenopausal Osteoporosis
Postmenopausal Osteoporosis
 
Non-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCPNon-contraceptive Benefits of COCP
Non-contraceptive Benefits of COCP
 
Managing Endometriosis
Managing EndometriosisManaging Endometriosis
Managing Endometriosis
 

Recently uploaded

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 

Recently uploaded (20)

Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 

Menopause

  • 2. How to diagnose Menopause? In a woman > 45 years of age, diagnose • Perimenopause • If she is having vasomotor symptoms and irregular periods • Menopause (with uterus) • If her last menstrual period was >12 months ago and she is not using hormonal contraception • Menopause (without uterus) • If she has climacteric symptoms NICE guideline : Menopause: diagnosis and management, 2015
  • 3. FSH measurement Consider using FSH to diagnose menopause only in: • Women aged 40-45 years with menopausal symptoms + change in menstrual cycle • Women aged <40 years in whom menopause is suspected • FSH > 35miu/ml in 2 separate occasions 6 weeks apart NICE guideline : Menopause: diagnosis and management, 2015
  • 4.
  • 5. Average age of Menopause • Mean age of menopause in Malaysia = 50.7 years • Average life expectancy of Malaysian women = 74 years First Consensus Meeting on Menopause in the East Asian Region – Menopause and HRT in Malaysia
  • 6. Physiology of Menopause • Menopause occurs when the ovary runs out of eggs • This results in reduced estradiol (E2) and increased FSH • Therefore, symptoms of menopause relate to estrogen deficiency During perimenopause, • There can be wide variation in hormone levels • Women can present with a mixture of both estrogen excess and estrogen deficiency symptoms • Symptoms of estrogen excess include breast tenderness, menorrhagia, migraine, nausea, shorter cycle length, shorter follicular phase
  • 7. Climacteric Symptoms MUM’S Vagina • Musculoskeletal symptoms • Joint and muscle pain • Urogenital symptoms • Vaginal dryness / itching, dyspareunia, urinary frequency/urgency • Mood changes • Irritability, depressive sx, sleep disturbance, reduced concentration • Sexual difficulties • Loss of libido • Vasomotor symptoms • Hot flushes, night sweats
  • 8. Symptom Prevalence In the US • African-American > Caucasian > Chinese > Japanese In the UK • 1 in 4 experience severe VMS • 1 in 3 experience severe psychological symptoms (anxiety, depression) • 1 in 2 experience moderate to severe symptoms of sleep disturbance, joint pain or headache • 1 in 4 have sexual problems F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
  • 9. Symptom Prevalence In Malaysia • 52% felt that symptoms affected their quality of life • Only 2.7% reported severe symptoms Bahiyah Abdullah et al, Prevalence of menopausal symptoms, its effect to quality of life among Malaysian women and their treatment seeking behaviour, Med J Malaysia Vol 72 Symptom Prevalence Joint pains / Muscular discomfort 24% Fatigue / Irritabiliry 60% VSM symptoms 55% Depression / Anxiety 45% Vaginal dryness 41% Sexual problems 35%
  • 10. Symptom Duration • There is no age limit at which menopausal symptoms cease • 10% of women have VMS 10 years after menopause • 16% of 85 year olds continue to experience VMS F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
  • 11. Other Health Consequences of Menopause Metabolic • Central abdominal fat deposition • Insulin resistance / T2DM Cardiovascular • Impaired endothelial function • Increased cholesterol Skeletal • Accelerated bone loss • Increased fracture risk
  • 12. Neurological • ? Cognitive performance decline Urogenital • Atrophic vaginitis • Urinary tract – frequency, cystitis, urge incontinence, dysuria Cancer • Breast / cervical / colon Other Health Consequences of Menopause
  • 13. Indications for starting HRT • Management of menopausal symptoms • VSM symptoms • Mood disorders • Altered sexual function • Urogenital atrophy • Prevention of Osteoporosis
  • 14. Indications for Treatment Complaint 1st line treatment 2nd line treatment Vasomotor symptoms HRT SSRI, SNRI, Clonidine Black cohosh Low mood HRT CBT SNRI/SSRI only for diagnosed depression Reduced libido HRT / Tibolone Add on Testosterone Urogenital atrophy Vaginal estrogen Add on moisturisers, lubricants High risk of osteoporosis HRT ( <60 yo) Bisphosphonates, Denosumab, SERM NICE guideline : Menopause: diagnosis and management, 2015
  • 15. Treatment options HRT • Estrogen only – ERT (Only to be used in women w/out uterus) • Oral / Patch / Vaginal • Estrogen + Progestogen – E+P • Oral / Patch • Continuous HRT or Sequential HRT Other options • Tibolone • TSEC (Tissue-selective estrogen complex therapy) • Estrogen + SERM • SSRI / SNRI
  • 16. Contraindication for HRT • History of breast cancer • History of VTE / stroke • Undiagnosed uterine bleeding • Significant cardiovascular disease • Hypersensitivity to estrogen • Active liver disease • Fibroids / endometriosis (Relative contraindications)
  • 17. Timing of Initiation • Best to start within 10 years of menopause • Should NOT start HRT above 60 yo without STRONG indication • In premature menopause, HRT is recommended until at least age of ‘natural’ menopause ie 50yo
  • 18. Dosages Use the LOWEST EFFECTIVE dose of estrogen consistent with TREATMENT GOALS • All women with an intact uterus will require progestogen. • Younger women generally require higher doses than older women
  • 19. Dosages Estrogen Standard dose Low dose Conjugated equine estrogen (CEE) 0.625mg 0.3mg 17ẞ estradiol valerate 2.0mg 0.5 – 1.0mg Micronised estradiol 1.0 – 2.0mg 0.25 – 0.5mg Transdermal estradiol 50-100mcg 25mcg Progestogen Standard dose Low dose Medroxyprogesterone acetate 2.5 – 5.0mg 1.5mg Norethisterone acetate (NETA) 1.0 – 2.0mg 0.1 – 0.5mg Drosperinone 2.0mg 0.5mg Micronised progesterone 100mc 50mg Tibolone Dose Tibolone 2.5mg daily
  • 20. Which is better? • CEE and Micronised Estradiol found to have lowest risk of increase in VTE • Micronised progesterone and Dydrogesterone found to have lower risk of breast cancer
  • 21. Pre-treatment evaluation General examination • Medical history • Family history • Weight/Height/BMI • Blood pressure • Breast examination • Bimanual examination • Papsmear Optional Investigations • Lipid profile • FBS • FBC • Buse/Cr • LFT • TFT • BMD • Mammogram Mammography screening should be done 2 yearly from 50-74 yo – US Preventive Task Force (USPTF) 2009
  • 22. Duration of use • NO MANDATORY duration • HRT can be given for AS LONG AS THE WOMAN WANTS IT • Ensure adequate supervision – annual risk-benefit assessment • Ensure woman aware of risks and benefits
  • 23. Clinical Side Effects of HRT Estrogen excess • Nausea, headache, breast tenderness • May be reduced by transdermal estrogen • Try changing to a different preparation E+P HT • Heavy bleeding, low mood • Micronised progesterone may have less mood side effects
  • 24. Long Term Effects of HRT • VTE • Stroke • Cardiovascular disease • Breast cancer • Type 2 diabetes • Osteoporosis NICE guideline : Menopause: diagnosis and management, 2015
  • 25. VTE and HRT • Micronised progesterone has lower risk of CTE compared to other types of progesterone • Estradiol may have lower risk of VTE compared to other types of estrogen • E only – 4 additional cases per 10 000 woman years • E+P – 6 additional cases per 10 000 woman years • Transdermal estrogen patch is NOT SHOWN to increase VTE • Patch should be used in women with increased risk of VTE R. J. Baber, N. Panay & A. Fenton the IMS Writing Group (2016) 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy, Climacteris, 19:2, 109-150, DOI: 10.3109- 13697137.2015.1129166
  • 26. Stroke and HRT • HRT in women <60 years of age and <10 years since menopause is not shown to increase risk in stroke • WHI study • Small increased risk of stroke in women taking oral estrogen >60 yo (but not transdermal estrogen!)
  • 27. Cardiovascular disease & HRT • HRT does NOT increase cardiovascular disease risk when started in women <60 yo • Risk of cardiovascular disease depends largely on other factors • HRT with estrogen alone is associated with no, or REDUCED risk of coronary heart disease • HRT with E+P is associated with little or no increase in the risk of coronary heart disease (up to 5 more women per 1000 women) • DOPs study – reduction in risk of CVD present up to 16 years later NICE guideline : Menopause: diagnosis and management, 2015
  • 28. Breast cancer & HRT • Estrogen ALONE is associated with little or NO CHANGE in the risk of breast cancer • E+P is associated with a small increase in risk of breast cancer • Up to 5 more cases per 1000 women • Any increase in risk will reduce after stopping HRT • Micronised progesterone may have lower risk NICE guideline : Menopause: diagnosis and management, 2015
  • 29. Type 2 diabetes & HRT • No contraindication for HRT • Not shown to have any impact on DM
  • 30. Osteoporosis and HRT • T-score • Osteopenia -1 to -2.4 • Osteoporosis -2.5 or lower • Osteoporosis depends on multiple factors including genetics and lifestyle • HRT significantly reduces the risk of fragility fracture but the benefits decrease once treatment is stopped • 23 fewer fractures per 1000 women NICE guideline : Menopause: diagnosis and management, 2015
  • 31. Summary of Long Term Effects of HRT E only E+P VTE Baseline risk 1:1000 +4 per 10 000 women No increase in transdermal +6 per 10 000 women Stroke Baseline risk 11:1000 No increase in transdermal +6 per 1000 women CHD Baseline risk 26:1000 -6 per 1000 women +5 per 1000 women Breast cancer Baseline risk 22:1000 -4 per 1000 women +5 per 1000 women Osteoporosis Baseline : variable -23 per 1000 women -23 per 1000 women NICE guideline : Menopause: diagnosis and management, 2015
  • 32. Summary of Long Term Effects of HRT E only E+P VTE Baseline risk 1:1000 + / = + Stroke Baseline risk 11:1000 + / = + CHD Baseline risk 26:1000  + Breast cancer Baseline risk 22:1000  + Osteoporosis Baseline : variable  
  • 33. Perimenopausal Women GOALS – Cycle control, Contraception, Symptom control • OCP • Rule out CI eg smoking, hypertension, dyslipidaemia, migraine, thrombosis risk, CVS risk • Consider switching to estradiol containing OCP rather than EE • Progestogen only contraception • Oral progestogens may be helpful in cycle control but not symptoms • LNG-IUS can be combined with oral estrogen for symptom control • Cyclical MHT • MHT does not suppress ovulation hence there may be symptoms of estrogen excess eg mastalgia, erratic bleeding
  • 34. Perimenopausal Women HRT is NOT EFFECTIVE CONTRACEPTION!
  • 35.
  • 36. Tibolone • Estrogenic, progestogenic and androgenic action • Contraindicated for breast cancer patients Improvement Increased Risk Libido / Osteoporosis / Stroke >60yo – 2x risk Breast cancer Reduced risk Colon cancer Reduced risk Endometrial hyperplasia No impact F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
  • 37. TSEC – Tissue-selectiveestrogencomplextherapy • SERM + Estrogen • CEE 0.45mg/day + Bazedoxifene 20mg /day • Reduces VMS • Improves urogenital atrophy • Preserves bone mass • Does not stimulate the endometrium • No evidence to increase VTE • No increase in breast cancer F. M. Jane & S.R. Davis (2014) A Practitioner’s Toolkit for Managing the Menopause, Climacteric 17:5, 564-579, DOI: 10.3109/13697137.2014.929651
  • 38. SSRI / SNRI • Second line treatment for VMS • May also improve mood and well-being • Not indicated for low mood without clinical depression
  • 39. HRT available in Malaysia Brand name Hormonal content Dosage Angeliq Estradiol hemihydrate + Drosperinone 1.0mg 2.0mg Climen - 16 pills - 12 pills Estradiol valerate Estradiol valerate + cyproterone acetate 2.0mg 2.0mg 1.0mg Divigel gel (28 sachets) Estradiol 1mg/g
  • 40. HRT available in Malaysia Brand name Hormonal content Dosage Femoston 2/10 14 pills 14 pills Estradiol Estradiol + dydrogesterone 2.0mg 2.0mg 10.0mg Femoston 1/10 14 pills 14 pills Estradiol Estradiol + dydrogesterone 1.0mg 1.0mg 10.0mg Femoston contii Estradiol + dydrogesterone 1.0mg 5.0mg
  • 41. HRT available in Malaysia Brand name Hormonal content Dosage Oestrogel gel 17ẞ estradiol 1.5mg/2.5g gel Permarin Conjugated equine estrogen 0.3mg, 0.625mg Premarin vaginal cream Conjugated equine estrogen 0.3mg/0.625mg/42.5g Premelle 2.5 CEE + MPA 0.625mg 2.5mg Premelle 5.0 CEE + MPA 0.625mg 5mg
  • 42. HRT available in Malaysia Brand Name Hormonal content Dosage Progynova Estradiol valerate 1.0mg or 2.0mg Progyluton - 11 pills - 10 pills Estradiol valerate Estradiol valerate + norgestrel 2.0mg 2.0mg 500mcg
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49. Summary • Current evidence indicates that HRT BENEFITS OUTWEIGHS HARM • HRT should be given to symptomatic women / women at high risk of osteoporotic fractures • Clinicians have an important role to offer HRT after appropriate counselling and ruling out any contraindications • The lowest dose of estrogen consistent with treatment goals should be used • HRT can be given for as long as the woman wants • Review women on HRT 6-12 monthly TRO any new contraindications • All menopausal women should be given advice on healthy lifestyle and ideal weight.